CD1D, CD1d molecule, 912

N. diseases: 140; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.030 Biomarker disease BEFREE Increases of CD1d immunoreactivity in the CNS of MS patients being greatest in areas of active demyelination and localized to GFAP-positive astrocytes lend support to the hypothesis of a lipid-targeted autoimmune process contributing to the pathogenesis of MS. 31050367 2020
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.030 Biomarker disease BEFREE Recent progress in identifying the nature of sphingolipids recognition for iNKT cells in immunity and the functional consequences of the lipid-CD1d interaction opens new avenues of access to the pathogenesis of demyelination in MS as well as design of lipid antigen-specific therapeutics. 29406905 2018
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.030 Biomarker disease BEFREE We have previously revealed that CD1d-restricted, V(alpha)24-J(alpha)Q NKT cells are remarkably reduced in the peripheral blood from MS. 14734607 2004